Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a
partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces
that KSF has commenced an investigation into IsoRay, Inc. (MYSE MKT:
ISR).
On May 21, 2015, TheStreet.com published an article claiming that
some of IsoRay’s promotional press releases “take liberties with
clinical data using clever, selective editing.” In particular, the
article stated that the Company’s recent press releases regarding the
publication of a study concerning its Celsium-131 product was misleading.
On this news, the price of MDC’s shares plummeted by over 35%.
KSF’s investigation is focusing on whether IsoRay and/or its officers
and directors violated state or federal securities laws.
If you are as IsoRay shareholder who has suffered losses related to your
investment or have information that would assist KSF in its
investigation, you may, without obligation or cost to you, call
toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com).
About Kahn Swick & Foti, LLC
KSF, whose partners include the Former Louisiana Attorney General
Charles C. Foti, Jr., is a law firm focused on securities class action
and shareholder derivative litigation with offices in New York,
California and Louisiana. KSF's lawyers have significant experience
litigating complex securities class actions nationwide on behalf of both
institutional and individual shareholders.
To learn more about KSF, you may visit www.ksfcounsel.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150521006605/en/
Copyright Business Wire 2015